Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fostemsavir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ViiV’s Rukobia wins EU authorisation to treat multidrug-resistant HIV
    ViiV’s Rukobia wins EU authorisation to treat multidrug-resistant HIV

    10 Feb 2021

    // Lucy Parsons PHARMATIMES

    http://www.pharmatimes.com/news/viivs_rukobia_wins_eu_authorisation_to_treat_multidrug-resistant_hiv_1363015

    Lucy Parsons PHARMATIMES
    10 Feb 2021
    Share Share
    ViiV's HIV drug Rukobia gets EC marketing authorisation
    ViiV's HIV drug Rukobia gets EC marketing authorisation

    09 Feb 2021

    // PHARMAFILE

    http://www.pharmafile.com/news/570715/viivs-hiv-drug-rukobia-gets-ec-marketing-authorisation

    PHARMAFILE
    09 Feb 2021
    Share Share
    GSK snags FDA nod for Rukobia in multidrug-resistant HIV
    GSK snags FDA nod for Rukobia in multidrug-resistant HIV

    06 Jul 2020

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/marketing/gsk-snags-first-class-fda-nod-for-rukobia-to-treat-hiv-patients-few-options

    Angus Liu FIERCE PHARMA
    06 Jul 2020
    Share Share
    ViiV Healthcare Announces US FDA Approval for Rukobia (fostemsavir)
    ViiV Healthcare Announces US FDA Approval for Rukobia (fostemsavir)

    02 Jul 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200702005580/en

    BUSINESSWIRE
    02 Jul 2020
    Share Share
    ViiV Healthcare submits regulatory application to the EMA for fostemsavir
    ViiV Healthcare submits regulatory application to the EMA for fostemsavir

    11 Jan 2020

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20200110005267/en

    BUSINESS WIRE
    11 Jan 2020
    Share Share